A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics.

Mitchell, Claire L; O'Connor, J P B; Roberts, C; Watson, Y; Jackson, A; Cheung, S; Evans, J; Spicer, J; Harris, A; Kelly, C; Rudman, S; Middleton, M; Fielding, A; Tessier, J; Young, H; Parker, G J M; Jayson, G C

Mitchell, Claire L; O'Connor, J P B; Roberts, C; Watson, Y; Jackson, A; Cheung, S; Evans, J; Spicer, J; Harris, A; Kelly, C; Rudman, S; Middleton, M; Fielding, A; Tessier, J; Young, H; Parker, G J M; Jayson, G C.

Affiliation

Mitchell CL; Department of Medical Oncology, Christie Hospital NHS Trust, Withington, Manchester, UK. Claire.Mitchell@christie.nhs.uk

Cancer Chemother Pharmacol ; 68(3): 631-41, 2011 Sep.

Article de En | MEDLINE | ID: mdl-21120480

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Quinazolines / Tumeurs Type d'étude: Clinical_trials / Prognostic_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Cancer Chemother Pharmacol Année: 2011 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google